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Abstract The fungal alkaloid militarinone A (MiliA) was
recently found to stimulate neuronal outgrowth in PC-12
cells by persistant activation of pathways that are also
involved in NGF-mediated differentiation, namely the PI3-
K/PKB and the MEK/ERK pathways. Application of equal
concentrations of MiliA to other cells such as the murine
neuroblastoma cell line N2a resulted in immediate onset of
apoptosis by nuclear translocation of apoptosis inducing
factor (AIF), activation of caspases and c-Jun/AP-1 tran-
scription factor without an intermediate differentiated
phenotype, although minor transient phosphorylation of
PKB and MAPK as well as activation of NF-jB were also
observed. Translocation of AIF was preceded by p53
phosphorylation at Ser15 and blocked by pifithrin a, a
known inhibitor of p53-transcriptional activity. We here
show that both cell types activate the same pathways albeit
in different time scales. This is mainly due to contrasting
basal expression levels of p53, which in turn regulates
expression of AIF. In PC-12 cells, continuous activation of
these pathways after prolonged treatment with 40 lM
MiliA first led to up-regulation of p53, phosphorylation of
p53, release of AIF from mitochondria and its translocation
into the nucleus. Additionally, also activation of the c-Jun/
AP-1 transcription factor was observed, and PC-12 cells
subsequently underwent apoptosis 48–72 h post-treatment.
We report that similar pathways working on different
levels are able to initially shape very divergent cellular
responses.
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Introduction
Neurotrophic factors are capable of preventing apoptosis in
neuronal cells, and exogenous supplementation with such
factors have been proposed as a new disease-modifying
strategy in the treatment of neurogenerative diseases.
However, clinical trials have been disappointing so far due
to difficulties in delivery of these glycoproteins into the
central nervous system [1]. Small non-peptidic molecules
with neurotrophic properties, and capable of penetrating
the blood–brain barrier, have been proposed as an alter-
native [2]. In the course of a screening for such molecules
we discovered that the fungal alkaloid militarinone A
(MiliA) induced neurite extension in PC-12 cells [3]. Due
to its amphiphilic properties MiliA was rapidly integrated
into the membranous fraction where it triggered PI3-K/
PKB- and ERK1/2-dependent differentiation [4, 5]. PKB
promotes survival of a variety of neuronal cells and has
been shown to be required for neuronal outgrowth [6, 7]. In
addition, phosphorylation and activation of the MAPKs
ERK1/2 [8] have also been connected with neuronal
differentiation [9], albeit its function is not fully clear.
Apoptosis inducing factor (AIF) is a mitochondrial
flavoprotein that is mainly located in the mitochondrial
intermembrane space. In healthy cells, AIF is required for
efficient oxidative phosphorylation. Upon apoptotic insult,
it translocates to the cytosol and subsequently into the
nucleus where it eventually binds to DNA and induces
caspase-independent cell death [10–12]. The concept that
AIF is able to induce apoptotic cell death independent of
caspases is supported by a series of experiments where
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programmed cell death was executed even in presence of
chemical caspase inhibitors such as Z-VAD-Fmk (zVAD)
or BAF. Moreover, AIF translocation was also observed in
mice in the absence of caspase activation [13], and the
biochemical changes were consistent with those described
in many caspase-dependent cell death models [14]. Con-
trasting with its death-inducing properties after nuclear
translocation, mitochondria-located AIF has been shown to
have a protective role in healthy and in tumour cells [11,
15]. Mitochondrial AIF is even thought to contribute to cell
survival by protecting cells against harmful oxidative
damage in the absence of deleterious stress while predis-
posing them to a more efficient killing in response to severe
stress. Recently, it has been reported that the aif gene is a
transcriptional target of basal levels of p53 [16].
p53 is a key tumour suppressor protein that is stabilised
and phosphorylated due to genotoxic stress and is nega-
tively controlled by Mdm2 which in turn is positively
controlled by PI3-K-PKB signalling [17, 18]. Once acti-
vated, p53 is able to promote cell-cycle arrest, apoptosis,
differentiation, senescence or DNA repair [19, 20]. It may
translocate to the nucleus where it regulates a plethora of
genes eventually leading to the expression of Bax, Bid, FAS
and redox-related genes. Therefore, a model was proposed
in which p53 initiates apoptosis through the regulation or
generation of reactive oxygen species (ROS) [21].
ROS are by-products of aerobic oxidation, mediate
toxicity but also work as signalling molecules [22]. Among
others, ROS activate diverse transcription factors such as
AP-1, antioxidant responsive element (ARE) and NF-jB
[23–25]. AP-1 describes a group of related members of the
Jun/Fos family and is involved in various cellular processes
depending on the composition of AP-1 dimers and on the
cell type. It is commonly thought that in neuronal cells,
c-jun has pro-apoptotic function [26], but a simple increase
of c-jun concentration was considered to be insufficient to
efficiently trigger neuronal cell death [27]. The contribu-
tion of AP-1 to survival, apoptosis or differentiation is
strictly depending on the cellular situation at a given time
point. ARE is important for cell defence under conditions
of oxidative stress [24], and NF-jB is a multifunctional
transcription factor mainly involved in promoting cell
survival [28].
Decline of mitochondrial integrity is considered to be of
major importance in generation of oxidative stress and
induction of apoptosis through the release of AIF and
cytochrome c [14, 29]. It is widely accepted that Bcl-2
proteins such as Bax or Bad are able to disturb the outer
mitochondrial membrane leading to the release of these
small molecules, and that other Bcl-2 proteins such as
Bcl-xL or Bcl-2 itself are capable to prevent this.
We report here that the small non-peptidic molecule
MiliA is capable of inducing signalling complexes such as
PI3-K/PKB, MEK/ERK, p53 and accumulation of ROS
that together contribute to neurite extension or/and apop-
tosis depending on the basal expressional level of p53.
Materials and methods
General remark
All experiments have been successfully reproduced at least
three times.
Materials and cell culture
Rat PC-12 cells were a kind gift from Prof. Anne Eckert
(Neurobiology Research Laboratory, University Clinic for
Psychiatry, Basel, Switzerland). Cells were maintained in
Dulbecco’s modified Eagle medium (DMEM; Sigma-
Aldrich, Buchs, Switzerland) supplemented with 5%
heat-inactivated foetal calf serum (FCS, Amimed, Basel,
Switzerland), 10% heat-inactivated horse serum (Amimed,
Basel, Switzerland), 100 U/ml penicillin/streptomycin
(Invitrogen, Basel, Switzerland), and 2 mM L-glutamine
(Invitrogen, Basel, Switzerland). Murine Neuro 2a (N2a)
cells were maintained in DMEM supplemented with 10%
FCS, 100 U/ml penicillin/streptomycin and 2 mM L-glu-
tamine. Both cell types were grown in humified atmosphere
containing 5% CO2. PC-12 cells stably overexpressing
TrkA were a kind gift from Prof. Frank-D. Bo¨hmer,
(Institute of Molecular Cell Biology, Jena, Germany) and
were treated as described [3]. The following chemicals
have been used: LY294.002, zVAD, pifithrin a (PFTa) (all
from Alexis Corporation, Lausen, Switzerland); N-Acetyl-
L-cysteine (NAC) and nerve growth factor (NGF) (both
from Sigma-Aldrich, Buchs, Switzerland). All chemical
inhibitors were added 30 min prior to stimulation.
Western blot
Immunoblot analysis was performed according to standard
procedures essentially as described [30]. Nitrocellulose
membranes were blocked and incubated overnight at 4C
with specific primary Ab diluted in blocking buffer (5%
BSA in TBS-Tween): anti-PKB 1:1000; anti-Phospho-PKB
(Ser473) 1:1000; anti-ERK1/2 1:2000; anti-Phospho-
ERK1/2 (Thr202/Tyr204) 1:1000; anti-AIF 1:2000; anti-
Phospho-p53 (Ser15) 1:2000 (all rabbit polyclonal); mouse
monoclonal anti-p53 1:1000 (all Cell Signaling Technol-
ogy, Beverly, MA, USA); goat polyclonal anti-Actin
1:4000 (Santa Cruz Biotechnology, Santa Cruz, CA, USA).
Specific bands were tagged using specific, HRP conjugated
secondary Abs and detected using the ECL Plus System
(GE Healthcare, Little Chalfont, UK).
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Immunofluorescence microscopy and light microscopy
PC-12 and N2a cells were fixed in 4% formaldehyde in PBS
for a minimal 15 min at 4C, permabilised with 0.2% Tri-
ton-X (prepared in PBS containing 10% heat-inactivated
FCS) and then incubated with primary Ab. The Abs were
diluted in PBS containing 10% heat-inactivated FCS and
used at the following conditions: rabbit polyclonal anti-AIF
(diluted 1:50), rabbit anti-Phospho-p53 (Ser15) (diluted
1:100), mouse monoclonal anti-p53 (diluted 1:200) (all
from Cell Signaling CST). Subsequently the cells were
washed thrice with PBS and incubated for 1 h with affinity-
purified Alexa-Fluor 488 goat anti-rabbit IgG (H + L) or
Alexa-Fluor 488 goat anti-mouse IgG (H + L) (both from
Invitrogen-Molecular Probes, Basel, Switzerland), respec-
tively. Nuclei were counterstained with Dapi (diluted
1:4000 in PBS) (from Invitrogen-Molecular Probes, Basel,
Switzerland). Cells plated on coverslips were mounted on
glass slides and visualised by confocal microscopy (Leica
DM RXE scanning confocal microscope) using Leica
confocal software, version 2.5 (Leica Microsystems,
Heidelberg, Germany) or on a fluorescence microscope
(Axiophot, Carl Zeiss AG, Jena, Germany) using the anal-
ySIS Software (Soft Imaging Systems, Mu¨nster, Germany).
Identical exposure times were used across conditions.
Light microscopy pictures were taken on a Leitz
Laborlux (Ernst Leitz, Wetzlar, Germany) equipped with a
Leica DC200 Camera (Leitz Microsystems AG, Glattbrugg,
Switzerland) and analysed with Leica DC Viewer Software
version 3,2,0,0 (Leica Microsystems AG, Heerbrugg,
Switzerland).
Flow cytometry and measurement of membrane
potential
To detect caspase activation, staining with FITC-valyl-
alanyl-aspartic acid fluoromethyl ketone (FITC-VAD-fmk;
Promega) was carried out as described [30]. Annexin V
staining of exposed membrane phosphatidylserine was
carried out using the Annexin V assay kit (Roche
Diagnostics, Rotkreuz, Switzerland) following the manu-
facturer’s protocol. Quantification of loss of membrane
potential was determined by incubating 1 9 106 cells with
2 nM DiOC6(3) in serum-reduced media at 37C for
30 min. After start of treatment, aliquots were taken at time
points indicated, diluted in PBS and subjected to flow
cytometry. FACS Analysis was performed on a Dako
CyAn
TM
ADP LX 7 using Summit software (DakoCyto-
mation, Fort Collins, CO, USA).
Measurement of intracellular ROS
The accumulation of ROS in PC-12 and N2a cells was
determined by analysis of dichlorofluorescein fluorescence.
Cells were plated in serum-containing DMEM into 96-well
plates and allowed to adhere overnight at 37C. After
washing twice with PBS, 2,7-dichlorofluorescein diacetate
(DCFH-DA; Invitrogen-Molecular Probes, Basel, Switzer-
land) was applied at 10 lM in PBS for 45 min at 37C.
After removal of the supernatant, cells were re-suspended
in serum-containing DMEM including drugs or vehicle
only and incubated for 60 min at 37C. DCF fluorescence
was quantified (excitation: 492 nm; emission: 535 nm)
using a Chameleon microplate reader (Hidex Oy, Turku,
Finland).
Alternatively, cells were left to grow on coverslips and
subsequently loaded with 5 lM DCFH-DA for 30 min.
After incubation with drugs in serum-containing DMEM,
the cells were fixed with MeOH at -20C for 5 min and
analysed by immunofluorescence microscopy as described
above. Identical exposure times were used across
conditions.
Preparation of nuclear extracts, electrophoretic mobility
shift assay and supershift
Cells were collected and washed with ice-cold PBS (pH 7.4)
and lysed in a hypotonic buffer (10 mM Hepes, pH 7.9,
60 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40) con-
taining protease inhibitors (1 mM PMSF, 19 Complete
Protease Inhibitors (Roche Diagnostics, Rotkreuz, Switzer-
land)). The nuclei were collected by centrifugation at 800g
for 5 min at 4C and washed once in ice-cold hypotonic
buffer without NP-40. Nuclei were subsequently re-sus-
pended in nuclear buffer (250 mM Tris–HCl, pH 7.8,
60 mM KCl, 1 mM EDTA, 1 mM DTT, 0.5% NP-40) con-
taining protease inhibitors (1 mM PMSF, 19 Complete
Protease Inhibitors). Nuclear membranes were disrupted by
freeze-thawing followed by centrifugation at 13,200g for
30 min. The supernatant (nuclear extract) was collected and
the protein concentration was measured using Coomassie
Protein Assay Reagent (Sigma-Aldrich, Buchs, Switzer-
land). The binding reactions were carried out as described
[31]. Briefly, nuclear extracts containing 3 lg nuclear pro-
teins were incubated for 20 min with 32P-radiolabelled
oligonucleotides in 20 ll reaction buffer. For supershift
analysis, 1 lg of anti-c-jun (Santa Cruz Biotechnology,
Santa Cruz, CA, USA) was added and incubated on ice for
another 30 min. Nuclear protein-oligonucleotide and anti-
body-protein-oligonucleotide complexes, respectively, were
resolved by electrophoresis on a 4% non-denaturing poly-
acrylamide gel in 0.259 TBE buffer at 20 V/cm for 35 min
at room temperature. The gel was dried and autoradio-
graphed on an intensifying screen at -80C. Double
stranded, palindromic oligonucleotides containing the con-
sensus sequences for ARE (50-AAA TGG CAT TGC TAA
TGG TGA CAA AGC AAC T-30) [32], NF-jB (50-AGT
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TGA GGG GAC TTT CCC AGG C-30) [31] or AP-1
(50-GAA TCG AGC ATG AGT CAG ACA CA-30) [33] were
used.
Results
We previously reported [3] that addition of 40 lM MiliA to
PC-12 cells for 24 h after pre-treatment with NGF [34]
induced neurite outgrowth which was attributed to the NGF-
dependent up-regulation of its receptor TrkA. However, pre-
treatment with a commercially available TrkA-inhibitor that
was able to prevent NGF-induced phosphorylation of PKB
and MAPKs, did not prevent MiliA-dependent phosphory-
lation of these proteins (Fig. 1a) and suggested that
phosphorylation of TrkA was not involved in MiliA-induced
neurite extension. When applying 40 lM MiliA to PC-12
cells stably over-expressing TrkA (TA) and naı¨ve PC-12, we
observed similar neuronal outgrowth in both cases (Fig. 1
and [3]. In addition, phosphorylation of PKB and MAPKs in
TA (not shown) and naı¨ve PC-12 was found (Fig. 1c).
Since up-regulation of the PKB and MAPK-pathways
was independent of TrkA, we wanted to know if MiliA-
induced phosphorylation of these signalling molecules
occurred also in other neuronal cell-lines. Treatment of
N2a cells with 40 lM MiliA led to a down-regulation of
the endogenous PKB and MAPK phosphorylation (Fig. 1
e). This was accompanied by a marked loss of protein
content from samples treated with MiliA compared to
vehicle-treated controls (not shown). Moreover, light
microscopy revealed that most of the cells had lost
adherence, were oddly shaped or had crumbled (Fig. 1d).
To discriminate between necrotic and apoptotic cell
death, we double-stained N2a cells treated with 40 lM
MiliA or vehicle only with Annexin V/PI. The over-
whelming part of cell death observed was due to apoptotic
mechanisms (Fig. 2a) becoming evident as early as 2 h
post-treatment. Additionally, chromatin condensation
Fig. 1 40 lM MiliA induced
TrkA-independent neurite
extension in PC-12, but
immediate apoptosis in N2a
cells. (a) Inhibition of TrkA
blocked NGF-dependent but not
MiliA-dependent
phophorylation of PKB and
ERk1/2. (b) PC-12 cells stably
transfected with TrkA (left
panels) and naı¨ve PC-12 (right
panels) showed similar neuronal
outgrowth after 24-h treatment
with MiliA. (c) Phosphorylation
of PKB (Ser473) and MAPKs
(ERK1/2; Thr202/Tyr204) was
clearly detected after 24 h in
PC-12 cells. (d) N2a cells lost
adherence and normal shape
upon addition of MiliA and (e)
no additional phosphorylation
of PKB (Ser473) nor MAPKs
(Thr202/Tyr204) could be
detected after 24 h
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occurred in cells treated with MiliA for 8 h or longer
(Fig. 2b), as visualised in N2a cells stained with Dapi. To
test if caspases were involved in the execution of the cel-
lular death observed, MiliA-treated N2a cells were stained
with the FITC tagged form of the general caspase inhibitor
zVAD and submitted to FACS-analysis: A distinct popu-
lation showing activation of caspases roughly doubled from
26.6 to 60% 24 h post-treatment (Fig. 2c). We tested in a
next step whether pre-treatment with zVAD (20 lM)
would be able to suppress onset of apoptosis, but addition
of zVAD only slightly diminished the extent of Annexin
V-positive cells by -2.3 ± 8.7% (data calculated from six
independent experiments), and a complete inhibition was
never observed after 3 h of treatment with 40 lM MiliA
(Fig. 2d). Besides, co-incubation of N2a cells with zVAD
and MiliA did not slow the progress of apoptosis, and a
phenotype showing neurite extension was observed neither
in absence nor in presence of zVAD. As caspase-inde-
pendent pathways could in addition be activated by
administration of MiliA, we checked for nuclear translo-
cation of AIF, a protein normally residing in the
mitochondrial intermembrane space [10]. In N2a cells, AIF
translocation was detected by confocal immunofluores-
cence microscopy as early as 4–6 h post-treatment
(Fig. 2e). When we checked for simultaneous release of
cytochrome c, another pro-apoptotic mitochondrial protein
[35], we failed to detect any significant change in locali-
sation (not shown). These findings suggested a specific
release of AIF.
As PC-12 showed neurite extension 1 day after addition
of 40 lM MiliA, we investigated the effect of prolonged
MiliA-treatment on PC-12 cells. Treatment for 1 day only
slightly elevated the quantity of Annexin V-positive and
Annexin V/PI double-positive cells, but these numbers were
substantially increasing after 3 days (Fig. 3a). However,
also PI-positive cells were observed and suggested addi-
tional necrotic mechanisms. Next we looked for caspase-
activation using FACS-analysis of FITC-VAD-Fmk-stained
cells but failed to detect any activation 1 day post-treatment
(Fig. 3b). Even after 2 days post-treatment, no activation
was observed (not shown). However, most of cells showed
clear nuclear translocation of AIF between 2 and 3 days
post-treatment (Fig. 3c) and analogous to the situation in
N2a cells, no significant change in cytochrome c localisa-
tion could be detected.
Militarinone A has been reported to rapidly integrate
into the membranous fraction [3] due to its amphiphilic
properties [36], whereas release into the cytoplasm was
markedly slower. As both PC-12 and N2a cells showed
release of AIF, we isolated whole, viable mitochondria
Fig. 2 Treatment with 40 lM
MiliA led to caspase-dependent
as well as -independent
apoptosis in N2a cells. (a) Early
signs of apoptosis by binding of
Annexin V to the cell surface
were detected as early as 2 h
after treatment with MiliA
(40 lM). (b) Late signs for
programmed cell death such as
chromatin condensation were
observed in cultures treated with
40 lM MiliA for 24 h. (c)
General activation of caspases
was detected by FACS analysis
of FITC-VAD-Fmk-stained
cells after 24 h. (d) Co-
treatment with the general
caspase inhibitor zVAD
(20 lM) led to only a marginal
reduction of programmed cell
death after 3 h as shown by
Annexin V/PI staining. (e)
Release and nuclear
translocation of AIF was
observed in cells treated for 4 h
or longer, as shown by confocal
immunofluorescence analysis
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from both cell lines to check for membranal integration of
MiliA. This rapidly occurred between 30 and 120 s after
addition of the compound and was indistinguishable from
integration into the cellular membrane (not shown) in both
cell types. This observation was unexpected given that N2a
showed release of AIF and early apoptosis whereas PC-12
displayed neurite outgrowth and a late onset of cell death.
As loss of membrane potential is a sign for the de-stabili-
sation of mitochondria and a pre-requirement for AIF-
release [37], we expected to see a rapid depolarisation in
N2a, and a significantly slower effect in PC-12. Loss of
membrane potential, however, took place at comparable
speed in both cell lines (Fig. 4a). We therefore postulated
that PC-12 cells would notwithstanding be less prone to the
release of ROS from mitochondria due to loss of membrane
potential and we visualised the occurrence of ROS-derived
oxidation by measurement of DCF fluorescence via
immunofluorescence microscopy. But again, both cell lines
reacted in a similar manner to the administration of MiliA
(Fig. 4b). When we quantitatively measured the production
of ROS we found no significant difference between PC-12
and N2a cells (Fig. 4c). Moreover, the production of ROS
by 40 lM MiliA was comparable to administration of
100 lM H2O2 and could be efficiently blocked by addition
of 15 mM NAC. Given the fact that between depolarisation
of the mitochondria and release of ROS, respectively, and
induction of cellular death passed several hours (N2a) or
even 1–3 days (PC-12), we assume that the release of ROS
resulted in activation of signalling pathways not directly
involved in apoptosis, as suggested by other publications
[38].
To test the involvement of ROS-production in the
propagation of apoptosis and neurite extension, respec-
tively, we co-treated both cell-lines with 40 lM MiliA and
15 mM NAC. PC-12 cells remained unaffected (not
shown) and N2a cells showed an apoptotic phenotype
indistinguishable from MiliA-only treated cells (Fig. 4d).
Even though NAC blocked accumulation of ROS (Fig. 4c),
the compound did not rescue N2a cells from cell death.
Neither loss of membrane potential nor increase of
ROS-levels sufficiently explained the marked difference in
reaction of PC-12 and N2a cells to MiliA treatment.
Therefore we tested for DNA-binding activities of tran-
scription factors that are reportedly activated by ROS, and
bind to consensus sequences of ARE, NF-jB and AP-1
[23–25]. ARE activity raised rapidly and transiently in N2a
and PC-12 after addition of MiliA, reaching its peak after
1 h (Fig. 5a) as shown by electrophoretic mobility shift
assay (EMSA). DNA-binding activity of AP-1 (Fig. 5b)
and NF-jB (Fig. 5c), on the other hand, were differentially
regulated in the two cell lines. N2a showed rapid induction
of NF-jB and AP-1-binding, peaking between 2 and 4 h.
Thereafter, no further activity could be detected. In PC-12
cells, binding of these two transcription factors was more
pronounced but only observed from 24–48 h post-
treatment.
To test if AP-1 and NF-jB were activated by ROS, we
incubated N2a and PC-12 cells pre-treated with 15 mM
NAC with MiliA for 4 and 24 h, respectively, and per-
formed EMSA. Only the NF-jB DNA-binding activity was
successfully inhibited by NAC in both cell lines (Fig. 5d),
whereas AP-1 remained unaffected (not shown). These
experiments suggested that ROS would not directly be
involved in MiliA-dependent apoptosis but could contrib-
ute to initial survival mechanisms mainly through NF-jB
activation.
p53 plays an important role in the management of
intracellular stress and regulates basal levels of AIF [16].
Fig. 3 PC-12 cells undergo homologous apoptosis as N2a cells upon
prolonged treatment with 40 lM MiliA. (a) Early signs for apoptosis
were detected after 1 day and became more pronounced after 3 days,
as shown by binding of Annexin V to the cell surface and FACS
Analysis in PC-12 cells. (b) General activation of caspases was not
detected by FACS analysis of FITC-VAD-Fmk stained cells after
1 day. (c) Translocation of AIF (green) into the nucleus (blue) in PC-
12 cells after a 3 day-treatment with MiliA (40 lM)
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Fig. 4 Immediate loss of membrane potential and release of ROS
were detected in both cell lines after addition of 40 lM MiliA. (a)
Loss of membrane potential was observed shortly after addition of
MiliA in PC-12 and N2a. (b) ROS production in both cell lines, as
shown by immunofluorescence analysis of DCF. (c) Production of
ROS quantitatively measured by DCF fluorescence in a multiplate
reader. Data shown were calculated from three independent exper-
iments and normalised to untreated cells. (d) N2a cells treated with
40 lM MiliA overnight underwent apoptosis and were not rescued by
addition of NAC (15 mM)
Fig. 5 Activation of the ARE, AP-1 and NF-jB transcription factors
after addition of 40 lM MiliA in both cell lines as revealed by
EMSA. DNA-binding activity of NF-jB was completely abolished by
addition of 15 mM NAC. (a) Increased transient binding to the ARE
consensus sequence was observed as early as 1 h post-treatment that
declined thereafter. There was no obvious difference in ARE DNA-
binding activity between PC-12 and N2a cells. (b) AP-1 and (c) NF-
jB were transiently activated in N2a cells peaking at around 2 h post-
treatment. PC-12 cells on the other hand showed more persistant
DNA-binding activities that began 24 h after start of treatment.(d)
Addition of 15 mM NAC completely inhibited MiliA-dependent NF-
jB DNA-binding activity in both cell lines
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AIF appears to play a dual role: it protects cells against
oxidative damage when located in the mitochondria, but
increases the chance to succumb to cell death in response to
severe stress and subsequent translocation of AIF. As there
was a distinct release and nuclear translocation of AIF in
both cell lines after addition of 40 lM MiliA, we analysed
the expression of p53. N2a cells showed a high basal
expression of p53 compared to PC-12 cells and a higher
expression of AIF (Fig. 6a). Treatment of PC-12 with
MiliA lead to up-regulation of p53, which was almost
exclusively localised in the nucleus, whereas N2a cells
showed a down-regulation 24 h post-treatment (Fig. 6b, c).
The stabilisation of p53 in PC-12 cells was unexpected,
since concommittant activation of PKB occurred (Fig. 1c).
PKB has been reported to negatively regulate p53 through
Mdm2 [17]. We, however, found that phosphorylation of
PKB positively regulated p53, as co-treatment with
LY294.002, a PI3-K-inhibitor, efficiently blocked PKB
phosphorylation and stabilisation of p53 (Fig. 6b). A sim-
ilar finding was previously published for p53 activation by
cisplatin that was equally blocked by the PI3-K-inhibitor
[39]. LY294.002, however, did not interfere with the
MiliA-dependent down-regulation but led to a slightly
diminished expression of basal p53 in untreated N2a cells
after incubation with LY294.002 for 1 day (Fig. 6b).
As we had suggested that high p53 expression in N2a
cells might be responsible for the sensitisation towards
apoptosis induced by MiliA, it was surprising to find p53
down-regulation after 24 h in N2a. However, this down-
regulation only occurred after induction of apoptosis. A
time course experiment of p53 expression did neither show
up- nor down-regulation within 4 h post-treatment (Fig. 6
d). To analyse activation of p53, we used an antibody
directed against the phosphorylated form of p53 (Ser15),
which was shown to be essential for its pro-apoptotic
activity [40, 41]. We, however, only found a significant
increase 4 h after addition of 40 lM MiliA, essentially
before AIF translocation was observed (Figs. 6e and 2e). In
PC-12 cells, stabilisation and activation by phosphorylation
of p53 was not observed before 24 h post-treatment, but
well before translocation of AIF could be detected
(Figs. 6e and 3c).
To check if activation of p53 was indeed responsible for
release of AIF and its nuclear translocation, we added
MiliA to cells pre-treated for 30 min with PFTa, a known
inhibitor of p53-transcriptional activity [42]. Consequently,
localisation of AIF remained unchanged in PFTa pre-
treated cells upon administration of MiliA in both cell
types after 6 h (N2a; Fig. 7a) and 3 days (PC-12; Fig. 7c),
respectively. Further, we checked if induction of apoptosis
could be blocked by pre-treatment with PFTa and/or PFTa/
zVAD combined treatment, which in fact was the case:
PFTa alone or in combination with zVAD efficiently
blocked initiation of apoptosis as measured by FACS of
Annexin V/PI-double stained cells in both N2a (Fig. 7b)
and PC-12 cells (Fig. 7d). zVAD (20 lM) alone, however,
Fig. 6 N2a showed higher expression of p53 and AIF compared to
PC-12 cells, and stabilisation of p53 was positively regulated by PI3-
K. (a) Protein levels of p53 and AIF were higher in N2a than in PC-12
cells. (b) Co-treatment with 50 lM LY294.002 efficiently inhibited
MiliA-dependent stabilisation (40 lM, 24 h) of p53 in PC-12 but did
not block down-regulation in N2a cells. It did, however, slightly
diminish basal expression of p53 in N2a cells. (c) p53 was almost
exclusively localised in the nucleus of PC-12 cells before and after
treatment with MiliA for 24 h (40 lM). (d) MiliA-dependent down-
regulation of p53 in N2a cells did not take place before 4 h post-
treatment. (e) Phosphorylation of p53 at Ser15 in response to
treatment with MiliA (40 lM)
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only showed marginal reduction of Annexin V-positive
cells in N2a and no reduction in PC-12. This is in agree-
ment with the finding that PC-12 showed no caspase-
activation in our assays in response to MiliA (Fig. 3b).
Even application of up to 100 lM zVAD did not block
onset of programmed cell death in neither cell line (not
shown).
As LY294.002 blocked stabilisation of p53, we tested if
treatment with the inhibitor 30 min prior to addition of
MiliA would reduce the extent of cell death in N2a.
Co-treatment with LY294.002 efficiently inhibited binding
of Annexin-V after 3 h, and only a fraction of the cells lost
their shape and adherence after 24 h (Fig. 8a, b).
As treatment with LY294.002 slightly reduced basal
levels of p53 in N2a cells (Fig. 6b), we investigated whether
phosphorylation at Ser15 of p53 would be repressed as well.
Use of an antibody directed against P-p53 in immunofluo-
rescence microscopy showed that activation of p53 by
40 lM MiliA was indeed affected by pre-treatment
with LY294.002 (Fig. 8c). 95.5 ± 4.1% of MiliA-treated
cells showed phosphorylation of p53 in immunofluores-
cence microscopy vs. 55.2 ± 4.2% in MiliA/LY294.002
co-treated cells (data calculated from three independent
experiments). This reduction was confirmed by analysis of
protein samples by SDS-PAGE (Fig. 8d) and was obviously
sufficient to prevent immediate onset of apoptosis. However,
MiliA-treated N2a cells in presence of LY294.002 suc-
cumbed to cell death between 24 and 48 h post-treatment
(not shown).
Given that pre-treatment with LY294.002 prolonged
survival of MiliA-treated N2a cells, we also applied the
PI3-K-inhibitor to PC-12 cells to see if neurite extension
and/or late apoptosis would be inhibited. However, PC-12
cells died within 24 h after addition of 50 lM LY294.002
in presence, but also in absence of 40 lM MiliA (not
shown). Therefore we continued with N2a cells and
observed postponed MiliA-dependent activation of the AP-
1 transcription factor in presence of LY294.002 24 h after
start of treatment. Interestingly, DNA-binding activity of
AP-1 was not detected in MiliA-only treated cells at this
time point (Figs. 9a and 5b). MiliA-dependent NF-jB
DNA-binding activity on the other hand remained
unchanged in presence or absence of LY294.002 (Fig. 5c
and not shown). We therefore tested the hypothesis, that
raised AP-1 DNA-binding activity is a pro-apoptotic event
in this context [43]. As binding of c-jun to AP-1 consensus
sequences is considered to be pro-apoptotic [26], we per-
formed supershift analysis using a specific antibody
directed against c-jun. We found c-jun-binding in both in
MiliA-treated N2a after 4 h as well as in PC-12 after 24 h
(Fig. 9b). In addition, the same supershift was also
observed in N2a cells co-treated with LY294.002 and
MiliA after 24 h (not shown).
Discussion
In this study we present evidence that a simple molecule by
activating identical pathways is able to trigger events as
diverse as neurite extension and apoptosis.
Differentiation is a complex process and involves
diverse signalling pathways. In PC-12 cells, neuronal dif-
ferentiation is usually initiated by the binding of NGF to
TrkA and involves the subsequent activation of PI3-K/
PKB, PKCs, Ras and MEK/ERK [5]. MiliA, a pyridone
alkaloid from Paecilomyces militaris [36] basically does
the same: it activates PKB and ERK1/2 [3] but circumvents
the need for TrkA. This results in neurite extension in PC-
12, and apoptosis in N2a cells. The outcome is similar to
that reported for geldanamycin, an Hsp90 inhibitor, which
provoked programmed cell death in PC-12 and neurite
extension in N2a cells [44]. In another study using a MiliA-
related compound, (+)-N-Deoxymilitarinone A, cytotoxic
effects were observed in the human neuroblastoma cell line
IMR-32, and neurite extension in PC-12 cells [45].
We report that MiliA is capable of initially driving two
basically independent signalling pathways. First, it pro-
vides NGF-like activity, leading to neurite extension. The
mechanism for activation of PI3-K/PKB and MEK/ERK1/
2, however, remains elusive. As MiliA showed high
affinity for membraneous compartments, we investigated
possible stimulation of the small G-proteins Ras and Rac
which are activated at the cytoplasmic side of the cellular
membrane [9, 46, 47] but could not detect any consisting
and specific activation neither at early nor late time points
(data not shown).
By additional insertion into mitochondrial membranes,
MiliA disturbed their integrity, which resulted in loss of
membrane potential, release and accumulation of ROS, in
both cell lines at comparable speed. Since addition of NAC
blocked increase of ROS in PC-12 and N2a, but not the
apoptotic pace, we assume that the release of oxidative
molecules from mitochondria did not trigger apoptosis by
itself. Furthermore, NAC did not inhibit cellular death in
N2a and blocked NF-jB-activation suggested that accu-
mulation of ROS was involved in defence and survival
mechanisms. The subsequent release of AIF and its trans-
location to the nucleus was fast in N2a but delayed in PC-
12, and suggests involvement of additional elements that
control release of molecules at mitochondrial level [48].
This was corroborated by the fact that we were unable to
detect co-release of cytochrome C. How exactly MiliA
induces loss of membrane potential, a necessary pre-req-
uisite for subsequent release of AIF [37], needs further
investigation.
Second, it activates p53-dependent apoptosis [19, 20]
mainly through a caspase-independent mechanism involv-
ing nuclear translocation of AIF, a molecule that is
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positively regulated by basal levels of p53 [16]. N2a
showed higher basal levels of p53 and AIF and underwent
apoptosis within a few hours whereas PC-12 had a low
p53-expression and first reacted with up-regulation of
protein-levels before execution of programmed cell death.
In the course of MiliA-induced signalling we found addi-
tional phosphorylation of p53 at Ser15, which is essential
for its pro-apoptotic function [40, 41]. Using PFTa, a
compound that does not inhibit p53 phosphorylation but its
transcriptional activity, abolished MiliA-dependent AIF
translocation and initiation of apoptosis. This suggests that
p53 was involved in regulation of AIF-expression and
localisation.
However, these pathways described are not independent
but interact with each other. Whereas inhibition of ERK1/
2-signalling by the MEK-inhibitor UO126 had not specific
effect (data not shown), blocking of the PI3-K/PKB path-
way by LY294.002 suppressed MiliA-dependent early
execution of apoptosis in N2a cells. This finding is in
contrast to reports showing that inhibition of PI3-K would
lead to stabilisation of p53 and facilitated induction of
apoptosis [17, 49]: rather on the contrary, basal expression
as well as phosphorylation at Ser15 were moderately
repressed. It is, however, in agreement with reports that
showed inhibition of cisplatin-induced, p53-dependent
apoptosis by LY294.002 [39]. Although the PI3-K/PKB-
pathway is mainly known for its pro-survival activity [50],
it contributes in this complex context to apoptosis-induc-
tion. Additionally, it postponed MiliA-dependent AP-1
DNA-binding activity.
A differentiated phenotype in N2a cells could not be
observed, which is likely due to the inhibition of PKB-
derived signalling. Unfortunately, this assumption could
not be verified in PC-12 cells as they fatally reacted to
PI3-K-inhibition as described.
It seems clear that the two cell-lines undergo apoptosis
through the same mechanisms once they are activated to a
similar extent. Further, it seems to be clear that MiliA-
dependent ROS-production does not play a decisive role as
Fig. 8 Inhibition of PI3-K by LY294.002 blocks immediate onset
of apoptosis in N2a cells and partly phosphorylation of p53 at
Ser15. (a) Co-treatment with 40 lM MiliA (3 h) and 50 lM
LY294.002 led to clearly reduced surface binding of Annexin V
compared to the vehicle-treated controls. (b) LY294.002 efficiently
inhibited late onset of cell death in N2a induced by 40 lM MiliA.
(c, d) There was incomplete but significant reduction in p53
phosphorylation in LY294.002 and MiliA co-treated N2a cells after
4 h as shown by immunofluorescence microscopy (c) and SDS-
PAGE (d)
Fig. 7 MiliA-dependent Apoptosis and nuclear translocation of AIF
is blocked by PFTa, an inhibitor of p53 transcriptional activity.
50 lM PFTa, 20 lM zVAD or PFTa and 20 lM zVAD were added
30 min prior to the administration of 40 lM MiliA. (a, c) N2a and
PC-12 cells were incubated with 50 lM PFTa prior to addition of
40 lM MiliA or vehicle only for 6 h (N2a) and 3 days (PC-12),
respectively. The cells were subsequently fixed, stained and analysed
for AIF localisation (green) by immunofluorescence microscopy. The
DNA was counterstained using Dapi (shown in blue). (b, d) FACS
analysis of Annexin V/PI double stained cells revealed a clear
reduction of Annexin V- and Annexin V/PI-positive N2a (b) or PC-12
(d) cells when co-treated with PFTa or PFTa/zVAD plus MiliA for
one (N2a) and 3 days (PC-12), respectively. Addition of zVAD alone
prior to MiliA-treatment only resulted in a minor reduction of
Annexin V-positive cells
b
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both showed almost identical ROS-up-regulation. We
nevertheless assume that it was involved to a certain
degree. ROS also act as secondary messengers in intra-
cellular signal transduction and help to induce or maintain
the oncogenic phenotype of cancer cells [51]. Treatment
with MiliA may just have driven the delicate balance over
the edge. Preliminary data suggest that MiliA-treated pri-
mary cells (bovine lymph node cells and murine bone
marrow mast cells) did not undergo cellular death even
after a week’s incubation. All cancer or cancerous cell lines
tested on the other hand (PC-12, N2a, IMR-32, Jurkat
T-cells, Theileria parva-infected T-cells [52]) died
between 8 and 72 h after start of treatment (P. Ku¨enzi and
M. Hamburger, unpublished results).
Conclusion
Militarinone A induces neurite extension in PC-12 cells by
persistent activation of pathways that are also involved in
NGF-mediated differentiation, namely the PI3-K/PKB and
MEK/ERK pathways. The continuous activation of these
pathways finally leads to up-regulation of p53, release of
AIF from mitochondria, and activation of the c-Jun/AP-1
transcription factor that has also been described as a ‘‘killer
on the transcriptional leash’’ [43]. Application of MiliA to
N2a cells, however, resulted in rapid onset of apoptosis by
nuclear translocation of AIF, activation of caspases and
c-Jun/AP-1. The main difference between the two cell
types was the basal expression of p53, being high in N2a
and low in PC-12. MiliA induced further stabilisation and
activation of p53 as well as p53-dependent release and
nuclear translocation of AIF in PC-12, which eventually
resulted in apoptosis. MiliA induced the self-same path-
ways in both cell lines, initially leading to diverse, but
finally to identical results.
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